• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

肿瘤血管破坏剂长春瑞滨及其两种杂芳基类似物对癌细胞、内皮细胞和血管的作用。

Effects of the tumor-vasculature-disrupting agent verubulin and two heteroaryl analogues on cancer cells, endothelial cells, and blood vessels.

机构信息

Organic Chemistry Laboratory, University of Bayreuth, Universitätsstraße 30, 95440 Bayreuth (Germany).

出版信息

ChemMedChem. 2014 Apr;9(4):847-54. doi: 10.1002/cmdc.201300531. Epub 2014 Feb 23.

DOI:10.1002/cmdc.201300531
PMID:24678059
Abstract

Two analogues of the discontinued tumor vascular-disrupting agent verubulin (Azixa®, MPC-6827, 1) featuring benzo-1,4-dioxan-6-yl (compound 5 a) and N-methylindol-5-yl (compound 10) residues instead of the para-anisyl group on the 4-(methylamino)-2-methylquinazoline pharmacophore, were prepared and found to exceed the antitumor efficacy of the lead compound. They were antiproliferative with single-digit nanomolar IC50 values against a panel of nine tumor cell lines, while not affecting nonmalignant fibroblasts. Indole 10 surpassed verubulin in seven tumor cell lines including colon, breast, ovarian, and germ cell cancer cell lines. In line with docking studies indicating that compound 10 may bind the colchicine binding site of tubulin more tightly (Ebind =-9.8 kcal mol(-1) ) than verubulin (Ebind =-8.3 kcal mol(-1) ), 10 suppressed the formation of vessel-like tubes in endothelial cells and destroyed the blood vessels in the chorioallantoic membrane of fertilized chicken eggs at nanomolar concentrations. When applied to nude mice bearing a highly vascularized 1411HP germ cell xenograft tumor, compound 10 displayed pronounced vascular-disrupting effects that led to hemorrhages and extensive central necrosis in the tumor.

摘要

两种已停产的肿瘤血管破坏剂长春瑞滨类似物(Azixa ® ,MPC-6827,1),其特征是苯并-1,4-二恶烷-6-基(化合物 5a)和 N-甲基吲哚-5-基(化合物 10)残基取代了 4-(甲氨基)-2-甲基喹唑啉药效团上的对茴香基,它们的抗肿瘤功效超过了先导化合物。它们对一组 9 种肿瘤细胞系具有抗增殖作用,IC50 值为个位数纳摩尔,而对非恶性成纤维细胞没有影响。吲哚 10 在包括结肠、乳腺、卵巢和生殖细胞癌细胞系在内的 7 种肿瘤细胞系中超过了长春瑞滨。与表明化合物 10 可能与微管蛋白的秋水仙碱结合位点结合更紧密(Ebind =-9.8 kcal mol(-1))而不是长春瑞滨(Ebind =-8.3 kcal mol(-1))的对接研究一致,10 抑制了内皮细胞中类似管状的管的形成,并在鸡胚的绒毛尿囊膜中以纳摩尔浓度破坏血管。当应用于携带高度血管化 1411HP 生殖细胞瘤异种移植瘤的裸鼠时,化合物 10 显示出明显的血管破坏作用,导致肿瘤出血和广泛的中心坏死。

相似文献

1
Effects of the tumor-vasculature-disrupting agent verubulin and two heteroaryl analogues on cancer cells, endothelial cells, and blood vessels.肿瘤血管破坏剂长春瑞滨及其两种杂芳基类似物对癌细胞、内皮细胞和血管的作用。
ChemMedChem. 2014 Apr;9(4):847-54. doi: 10.1002/cmdc.201300531. Epub 2014 Feb 23.
2
Quinazoline-based multi-tyrosine kinase inhibitors: synthesis, modeling, antitumor and antiangiogenic properties.基于喹唑啉的多酪氨酸激酶抑制剂:合成、建模、抗肿瘤和抗血管生成特性。
Eur J Med Chem. 2013 Sep;67:373-83. doi: 10.1016/j.ejmech.2013.06.057. Epub 2013 Jul 6.
3
Synthesis and antitumor activities evaluation of m-(4-morpholinoquinazolin-2-yl)benzamides in vitro and in vivo.间位-(4-吗啉基喹唑啉-2-基)苯甲酰胺的体外和体内合成及抗肿瘤活性评估
Eur J Med Chem. 2015;96:382-95. doi: 10.1016/j.ejmech.2015.04.037. Epub 2015 Apr 17.
4
Inhibition of tumor cell growth and angiogenesis by 7-aminoalkoxy-4-aryloxy-quinazoline ureas, a novel series of multi-tyrosine kinase inhibitors.新型多酪氨酸激酶抑制剂7-氨基烷氧基-4-芳氧基喹唑啉脲对肿瘤细胞生长和血管生成的抑制作用
Eur J Med Chem. 2014 May 22;79:369-81. doi: 10.1016/j.ejmech.2014.04.007. Epub 2014 Apr 5.
5
MPC-6827: a small-molecule inhibitor of microtubule formation that is not a substrate for multidrug resistance pumps.MPC - 6827:一种微管形成的小分子抑制剂,并非多药耐药泵的底物。
Cancer Res. 2007 Jun 15;67(12):5865-71. doi: 10.1158/0008-5472.CAN-07-0127.
6
The microtubule depolymerizing agent CYT997 causes extensive ablation of tumor vasculature in vivo.微管去聚合剂 CYT997 在体内引起广泛的肿瘤血管消融。
J Pharmacol Exp Ther. 2011 Dec;339(3):799-806. doi: 10.1124/jpet.111.186965. Epub 2011 Sep 14.
7
Combretastatin A-4 derived 5-(1-methyl-4-phenyl-imidazol-5-yl)indoles with superior cytotoxic and anti-vascular effects on chemoresistant cancer cells and tumors.具有优越细胞毒性和抗血管生成作用的来源于康普瑞汀 A-4 的 5-(1-甲基-4-苯基-咪唑-5-基)吲哚类衍生物,用于化疗耐药的癌细胞和肿瘤。
Eur J Med Chem. 2016 Aug 8;118:9-20. doi: 10.1016/j.ejmech.2016.04.045. Epub 2016 Apr 19.
8
Evaluation of the antitumor activity of NOV202, a novel microtubule targeting and vascular disrupting agent.新型微管靶向和血管破坏剂NOV202的抗肿瘤活性评估
Drug Des Devel Ther. 2017 Apr 28;11:1335-1351. doi: 10.2147/DDDT.S133189. eCollection 2017.
9
4-(3-Halo/amino-4,5-dimethoxyphenyl)-5-aryloxazoles and -N-methylimidazoles that are cytotoxic against combretastatin A resistant tumor cells and vascular disrupting in a cisplatin resistant germ cell tumor model.4-(3-卤代/氨基-4,5-二甲氧基苯基)-5-芳基恶唑和-N-甲基咪唑类化合物,对 combretastatin A 耐药肿瘤细胞具有细胞毒性,并在顺铂耐药生殖细胞瘤模型中具有血管破坏作用。
J Med Chem. 2010 Sep 23;53(18):6595-602. doi: 10.1021/jm100345r.
10
Design, synthesis and biological evaluation of a series of pyrano chalcone derivatives containing indole moiety as novel anti-tubulin agents.一系列含吲哚基团的吡喃查尔酮衍生物作为新型抗微管蛋白剂的设计、合成及生物学评价
Bioorg Med Chem. 2014 Apr 1;22(7):2060-79. doi: 10.1016/j.bmc.2014.02.028. Epub 2014 Mar 1.

引用本文的文献

1
Verubulin (Azixa) Analogues with Increased Saturation: Synthesis, SAR and Encapsulation in Biocompatible Nanocontainers Based on Ca or Mg Cross-Linked Alginate.饱和度增加的维鲁布林(阿齐萨)类似物:基于钙或镁交联藻酸盐的生物相容性纳米容器中的合成、构效关系及包封
Pharmaceuticals (Basel). 2023 Oct 21;16(10):1499. doi: 10.3390/ph16101499.
2
Design, Synthesis, and Biological Evaluation of Pyrimidine Dihydroquinoxalinone Derivatives as Tubulin Colchicine Site-Binding Agents That Displayed Potent Anticancer Activity Both In Vitro and In Vivo.嘧啶二氢喹喔啉酮衍生物作为微管蛋白秋水仙碱位点结合剂的设计、合成及生物学评价,其在体外和体内均显示出强大的抗癌活性。
ACS Pharmacol Transl Sci. 2023 Mar 22;6(4):526-545. doi: 10.1021/acsptsci.2c00108. eCollection 2023 Apr 14.
3
Molecular interactions at the colchicine binding site in tubulin: An X-ray crystallography perspective.微管蛋白秋水仙碱结合部位的分子相互作用:X 射线晶体学视角。
Drug Discov Today. 2022 Mar;27(3):759-776. doi: 10.1016/j.drudis.2021.12.001. Epub 2021 Dec 8.
4
X-ray Crystallography-Guided Design, Antitumor Efficacy, and QSAR Analysis of Metabolically Stable Cyclopenta-Pyrimidinyl Dihydroquinoxalinone as a Potent Tubulin Polymerization Inhibitor.X射线晶体学引导设计、代谢稳定的环戊基嘧啶基二氢喹喔啉酮作为一种有效的微管蛋白聚合抑制剂的抗肿瘤功效及定量构效关系分析
J Med Chem. 2021 Sep 9;64(17):13072-13095. doi: 10.1021/acs.jmedchem.1c01202. Epub 2021 Aug 18.
5
Utilisation of Chick Embryo Chorioallantoic Membrane as a Model Platform for Imaging-Navigated Biomedical Research.利用鸡胚尿囊膜作为成像导航生物医学研究的模型平台。
Cells. 2021 Feb 22;10(2):463. doi: 10.3390/cells10020463.
6
Microwave-Assisted Synthesis of Potential Bioactive Benzo-, Pyrido- or Pyrazino-thieno[3,2-]pyrimidin-4-amine Analogs of MPC-6827.微波辅助合成MPC-6827的潜在生物活性苯并、吡啶并或吡嗪并噻吩并[3,2-]嘧啶-4-胺类似物
Pharmaceuticals (Basel). 2020 Aug 19;13(9):202. doi: 10.3390/ph13090202.
7
Current advances of tubulin inhibitors as dual acting small molecules for cancer therapy.作为双重作用的小分子,微管抑制剂在癌症治疗中的最新进展。
Med Res Rev. 2019 Jul;39(4):1398-1426. doi: 10.1002/med.21568. Epub 2019 Feb 11.
8
Oxazole-Bridged Combretastatin A-4 Derivatives with Tethered Hydroxamic Acids: Structure⁻Activity Relations of New Inhibitors of HDAC and/or Tubulin Function.唑桥连康普瑞汀 A-4 衍生物与桥连羟肟酸:新型 HDAC 和/或微管蛋白功能抑制剂的构效关系。
Int J Mol Sci. 2019 Jan 17;20(2):383. doi: 10.3390/ijms20020383.
9
Radiosynthesis and in Vivo Evaluation of [C]MPC-6827, the First Brain Penetrant Microtubule PET Ligand.[C]MPC-6827 的放射性合成及体内评价,首个穿透血脑屏障的微管 PET 配体。
J Med Chem. 2018 Mar 8;61(5):2118-2123. doi: 10.1021/acs.jmedchem.8b00028. Epub 2018 Feb 23.
10
Heterocyclic-Fused Pyrimidines as Novel Tubulin Polymerization Inhibitors Targeting the Colchicine Binding Site: Structural Basis and Antitumor Efficacy.杂环稠合嘧啶类化合物作为新型微管蛋白聚合抑制剂靶向秋水仙碱结合位点:结构基础和抗肿瘤功效。
J Med Chem. 2018 Feb 22;61(4):1704-1718. doi: 10.1021/acs.jmedchem.7b01858. Epub 2018 Feb 12.